A Study of Flexible Dose Brexpiprazole as Monotherapy or Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder (PTSD)
Clinical trial NCT03033069 · COMPLETED
Trial details
- NCT number
- NCT03033069
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-26
- Primary completion
- 2018-11-12
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.